An unsuspected role for organic cation transporter 3 in the actions of amphetamine

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Felix P MayerHarald H Sitte

Abstract

Amphetamine abuse is a major public health concern for which there is currently no effective treatment. To develop effective treatments, the mechanisms by which amphetamine produces its abuse-related effects need to be fully understood. It is well known that amphetamine exerts its actions by targeting high-affinity transporters for monoamines, in particular the cocaine-sensitive dopamine transporter. Organic cation transporter 3 (OCT3) has recently been found to play an important role in regulating monoamine signaling. However, whether OCT3 contributes to the actions of amphetamine is unclear. We found that OCT3 is expressed in dopamine neurons. Then, applying a combination of in vivo, ex vivo, and in vitro approaches, we revealed that a substantial component of amphetamine's actions is OCT3-dependent and cocaine insensitive. Our findings support OCT3 as a new player in the actions of amphetamine and encourage investigation of this transporter as a potential new target for the treatment of psychostimulant abuse.

References

Feb 1, 1988·Journal of Neurochemistry·S P ButcherG W Arbuthnott
Apr 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·E SchömigH Russ
Nov 5, 1997·Advances in Pharmacology·E SchömigD Gründemann
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·S R JonesM G Caron
Apr 10, 2002·The Journal of Biological Chemistry·Petra ScholzeHarald H Sitte
Aug 16, 2002·The Journal of Physiology·Doris KristufekSigismund Huck
Jun 16, 2005·Progress in Neurobiology·David SulzerAurelio Galli
Aug 16, 2005·Molecular Pharmacology·Karen Engel, Joanne Wang
Oct 3, 2006·Alcoholism, Clinical and Experimental Research·Nagisa AoyamaNorio Ozaki
Jan 25, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kevin ErregerAurelio Galli
Nov 26, 2008·The Journal of Comparative Neurology·Paul J GasserChristopher A Lowry
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Nicole L BaganzLynette C Daws
Mar 13, 2009·Journal of Neural Transmission·Thomas WultschAndreas Reif
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mei CuiKim Tieu
Nov 7, 2009·Journal of Neurochemistry·Harald H Sitte, Michael Freissmuth
Jul 15, 2011·Pharmacological Reviews·Anders S KristensenUlrik Gether
Jun 21, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rebecca E HortonLynette C Daws
Jul 19, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evan N GrafPaul J Gasser
Nov 21, 2013·British Journal of Pharmacology·Walter SandtnerHarald H Sitte
Feb 4, 2014·Advances in Pharmacology·Leonard L Howell, S Stevens Negus
Apr 18, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cody A SicilianoSara R Jones

❮ Previous
Next ❯

Citations

Mar 19, 2020·International Journal of Molecular Sciences·Darcy C EngelhartSanjay K Nigam
May 2, 2020·Journal of Neurochemistry·Suzanne O NolanErin S Calipari
Dec 20, 2019·Pharmacological Reviews·Hermann Koepsell
Feb 8, 2021·Archives of Toxicology·Rita Roque BravoDiana Dias da Silva

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence-activated
transgenic
Fluorescence
FACS
electron microscopy

Software Mentioned

GENSAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.